Comparative efficacy of oral traditional Chinese patent medicine for acute cerebral infarction: protocol for network meta-analysis of randomized controlled trials
Cui, R., Xing, L., Robinson, N., Yu, D., Zhao, J. and Zhao, H. (2019). Comparative efficacy of oral traditional Chinese patent medicine for acute cerebral infarction: protocol for network meta-analysis of randomized controlled trials. European Journal of Integrative Medicine. 32. https://doi.org/10.1016/j.eujim.2019.100977
|Authors||Cui, R., Xing, L., Robinson, N., Yu, D., Zhao, J. and Zhao, H.|
Traditional Chinese patent medicines (TCPMs) are widely used in the treatment of ACI in China. Many oral traditional Chinese patent medicines have been reported to be effective for acute cerebral infarction (ACI). However, a comparison of randomized controlled trials (RCTs) to directly compare the efficacy of different oral TCPMs has not been performed. There is no evidence to demonstrate which of oral TCPMs more effective for clinicians. Therefore, we plan to conduct a systematic review and network meta-analysis (NMA) to compare the efficacy of 10 kinds of oral TCPMs for ACI. The aim is to provide the best currently available evidence base to guide the selection of oral TCPMs.
The protocol has been registered on PROSPERO (International Prospective Register of Systematic Reviews) (CRD42018110307).
|Journal||European Journal of Integrative Medicine|
|Digital Object Identifier (DOI)||https://doi.org/10.1016/j.eujim.2019.100977|
|Web address (URL)||https://www.sciencedirect.com/science/article/abs/pii/S1876382019306900|
|Online||14 Sep 2019|
|Publication process dates|
|Accepted||13 Sep 2019|
|Deposited||11 Oct 2019|
|Accepted author manuscript|
File Access Level
2views this month
0downloads this month